US pharma giants eye India’s obesity crisis with pricey shots, sparking ‘Make in India’ and affordability debates ...
Ben McPoland considers a pair of investments that are performing awfully in his ISA portfolio so far this year. What's gone ...
Q4 2024 Earnings Call Transcript March 20, 2025 Operator: Ladies and gentlemen, thank you for standing by. My name is Jale, and I will be your conference operator today. At this time, I would like to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback